207 related articles for article (PubMed ID: 36115894)
1. Microarray profiling identifies hsa_circ_0082003 as a novel tumor promoter for papillary thyroid carcinoma.
Ye J; Feng JW; Wu WX; Qi GF; Wang F; Hu J; Hong LZ; Liu SY; Jiang Y
J Endocrinol Invest; 2023 Mar; 46(3):509-522. PubMed ID: 36115894
[TBL] [Abstract][Full Text] [Related]
2. Circular RNA hsa_circ_0001666 sponges miR‑330‑5p, miR‑193a‑5p and miR‑326, and promotes papillary thyroid carcinoma progression via upregulation of ETV4.
Qi Y; He J; Zhang Y; Wang L; Yu Y; Yao B; Tian Z
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33760216
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic potential of two exosome-derived circRNAs for papillary thyroid cancer.
Dai L; Hu W; Jiang H; Wang Y; Le Q; Wu X; Meng X
Int J Clin Oncol; 2023 Nov; 28(11):1461-1474. PubMed ID: 37568034
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA profiling reveals a potential role of hsa_circ_IPCEF1 in papillary thyroid carcinoma.
Guo M; Sun Y; Ding J; Li Y; Yang S; Zhao Y; Jin X; Li SS
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165176
[TBL] [Abstract][Full Text] [Related]
5. Hsa_circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the NOTCH3/GATAD2A axis.
Yao Y; Chen X; Yang H; Chen W; Qian Y; Yan Z; Liao T; Yao W; Wu W; Yu T; Chen Y; Zhang Y
J Exp Clin Cancer Res; 2019 Jul; 38(1):318. PubMed ID: 31324198
[TBL] [Abstract][Full Text] [Related]
6. Hsa_circ_0039411 promotes tumorigenesis and progression of papillary thyroid cancer by miR-1179/ABCA9 and miR-1205/MTA1 signaling pathways.
Yang Y; Ding L; Li Y; Xuan C
J Cell Physiol; 2020 Feb; 235(2):1321-1329. PubMed ID: 31270819
[TBL] [Abstract][Full Text] [Related]
7. Increased Expression of hsa_circ_0002111 and Its Clinical Significance in Papillary Thyroid Cancer.
Du G; Ma R; Li H; He J; Feng K; Niu D; Yin D
Front Oncol; 2021; 11():644011. PubMed ID: 33718243
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of hsa_circ_0137287 predicts aggressive clinicopathologic characteristics in papillary thyroid carcinoma.
Lan X; Cao J; Xu J; Chen C; Zheng C; Wang J; Zhu X; Zhu X; Ge M
J Clin Lab Anal; 2018 Oct; 32(8):e22573. PubMed ID: 29790216
[TBL] [Abstract][Full Text] [Related]
9. Hsa_circ_0092355 Accelerates Papillary Thyroid Cancer Progression by Regulating the miR-543/PDE5A Pathway.
Sun Z; Zhang M; Ye Y; Yang L
Horm Metab Res; 2024 May; 56(5):381-391. PubMed ID: 38286403
[TBL] [Abstract][Full Text] [Related]
10. circ_0005273 promotes thyroid carcinoma progression by SOX2 expression.
Zhang W; Zhang H; Zhao X
Endocr Relat Cancer; 2020 Jan; 27(1):11-21. PubMed ID: 31693489
[TBL] [Abstract][Full Text] [Related]
11. Circ_0079558 promotes papillary thyroid cancer progression by binding to miR-26b-5p to activate MET/AKT signaling.
Zheng H; Fu Q; Ma K; Shi S; Fu Y
Endocr J; 2021 Nov; 68(11):1247-1266. PubMed ID: 34565758
[TBL] [Abstract][Full Text] [Related]
12. Upregulated hsa_circ_0004458 Contributes to Progression of Papillary Thyroid Carcinoma by Inhibition of miR-885-5p and Activation of RAC1.
Jin X; Wang Z; Pang W; Zhou J; Liang Y; Yang J; Yang L; Zhang Q
Med Sci Monit; 2018 Aug; 24():5488-5500. PubMed ID: 30086127
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive circular RNA profiling reveals the regulatory role of circRNA_0007694 in papillary thyroid carcinoma.
Long MY; Chen JW; Zhu Y; Luo DY; Lin SJ; Peng XZ; Tan LP; Li HH
Am J Transl Res; 2020; 12(4):1362-1378. PubMed ID: 32355548
[TBL] [Abstract][Full Text] [Related]
14. Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis.
Liu Y; Chen G; Wang B; Wu H; Zhang Y; Ye H
Endocr J; 2021 Jun; 68(6):713-727. PubMed ID: 33716239
[TBL] [Abstract][Full Text] [Related]
15. Microarray profiling of circular RNAs in human papillary thyroid carcinoma.
Peng N; Shi L; Zhang Q; Hu Y; Wang N; Ye H
PLoS One; 2017; 12(3):e0170287. PubMed ID: 28288173
[TBL] [Abstract][Full Text] [Related]
16. Has_circ_0008274 promotes cell proliferation and invasion involving AMPK/mTOR signaling pathway in papillary thyroid carcinoma.
Zhou GK; Zhang GY; Yuan ZN; Pei R; Liu DM
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8772-8780. PubMed ID: 30575918
[TBL] [Abstract][Full Text] [Related]
17. Profile and clinical implication of circular RNAs in human papillary thyroid carcinoma.
Ren H; Liu Z; Liu S; Zhou X; Wang H; Xu J; Wang D; Yuan G
PeerJ; 2018; 6():e5363. PubMed ID: 30123704
[TBL] [Abstract][Full Text] [Related]
18. Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients.
Shen C; Wu Z; Wang Y; Gao S; Da L; Xie L; Qie Y; Tian D; Hu H
Cancer Med; 2020 Jun; 9(11):3885-3903. PubMed ID: 32250047
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of circPUM1 impedes cell growth, metastasis and glycolysis of papillary thyroid cancer via enhancing MAPK1 expression by serving as the sponge of miR-21-5p.
Li Y; Qin J; He Z; Cui G; Zhang K; Wu B
Genes Genomics; 2021 Feb; 43(2):141-150. PubMed ID: 33481227
[TBL] [Abstract][Full Text] [Related]
20. The Landscape of Circular RNA Expression Profiles in Papillary Thyroid Carcinoma Based on RNA Sequencing.
Lan X; Xu J; Chen C; Zheng C; Wang J; Cao J; Zhu X; Ge M
Cell Physiol Biochem; 2018; 47(3):1122-1132. PubMed ID: 29847813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
